KYMR Projected Dividend Yield
Kymera Therapeutics Inc ( NASDAQ : KYMR )Kymera Therapeutics, Inc. is a biopharmaceutical company. Co. is focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. Co.'s targeted protein degradation (TPD) platform, which it refers to as Pegasus, allows it to discover highly selective small molecule protein degraders with activity against disease-causing proteins throughout the body. It utilized its Pegasus platform to design novel protein degraders focused in the areas of immunology-inflammation and oncology, and it continues to apply its platform's capabilities to additional therapeutic areas. 21 YEAR PERFORMANCE RESULTS |
KYMR Dividend History Detail KYMR Dividend News KYMR Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |